4//SEC Filing
Danahy Kevin Patrick 4
Accession 0001437749-23-019993
CIK 0001625101other
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 8:29 PM ET
Size
5.4 KB
Accession
0001437749-23-019993
Insider Transaction Report
Form 4
Danahy Kevin Patrick
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2023-07-12+200,000→ 200,000 totalExercise: $7.08Exp: 2033-07-12→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]The option was granted on July 12, 2023 under the Issuer's 2017 Equity Incentive Plan. The shares subject to the option are subject to two tranches of performance-based vesting criteria tied to Issuer's market capitalization, with no vesting until the Issuer's market capitalization exceeds $4 billion, in both cases, subject to the Reporting Person's continued service through each vesting milestone.
- [F2]Not applicable.
Documents
Issuer
Pulse Biosciences, Inc.
CIK 0001625101
Entity typeother
Related Parties
1- filerCIK 0001913245
Filing Metadata
- Form type
- 4
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 8:29 PM ET
- Size
- 5.4 KB